Showing results (321-330 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|June 5, 2013
PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic markerZhe Su, Hua Tian, Hong-quan Song, et al.
Medical Oncology (Northwood, London, England)|June 18, 2013
The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcomeSan-Zhong Li, Yong-Bo Zhao, Wei-Dong Cao, et al.
Medical Oncology (Northwood, London, England)|April 9, 2013
Appropriateness of cardiovascular care in elderly adult cancer survivorsWinson Y Cheung, Raisa Levin, Soko Setoguchi
Medical Oncology (Northwood, London, England)|April 10, 2013
Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patientsM C Souza, C A Rodrigues, M R R Silva, et al.
Medical Oncology (Northwood, London, England)|April 10, 2013
P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancerSasmit Sarangi, Ambarish Pandey, Anne-Laure Papa, et al.
Medical Oncology (Northwood, London, England)|March 29, 2013
Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinomaWei Gao, Xue Bing, MingYan Li, et al.
Medical Oncology (Northwood, London, England)|March 30, 2013
Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapyMinoru Kobayashi, Taro Kubo, Kenji Komatsu, et al.
Medical Oncology (Northwood, London, England)|June 25, 2013
Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancerAna Božović, Milan Markićević, Bogomir Dimitrijević, et al.
Medical Oncology (Northwood, London, England)|July 23, 2013
Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese populationZhen-Bin Ma, Kun Li, Jian Wang, et al.
Medical Oncology (Northwood, London, England)|July 24, 2013
Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?Leyla Kilic, Cetin Ordu, Meltem Ekenel, et al.
Pageof 570